Clinical Trial Update: A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA) [Phase 2]

View source ↗

Summary

Phase 2 trial results for Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in participants with chronic kidney disease have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Disease, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2016-06-14